🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › Sgìre Cholumbia › Washington

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Washington, DC

Tha aon sgrùdadh airson Cancer briste triple-negative a’ lorg phàirtichean aig làrach ann no faisg air Washington. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

A’ fastadhSgrùdadh amharc
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07619534

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

A’ fastadhÌre 3
  • Washington Hospital Center ( Site 0098), Washington D.C.
  • Holy Cross Hospital ( Site 0091), Silver Spring · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

A’ fastadhÌre 3
  • Holy Cross Hospital ( Site 0069), Silver Spring · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06393374

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

A’ fastadhÌre 1
  • Georgetown University Medical Center, Washington D.C.
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05983432

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

A’ fastadhÌre 3
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05633654

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

A’ fastadh
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT07067138

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

A’ fastadhÌre 1
  • Normunity Investigational Site, Washington D.C.
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149

Study of XB010 in Subjects With Solid Tumors

A’ fastadhÌre 1
  • Georgetown University Medical Center, Washington D.C.
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT06545331

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

A’ fastadhÌre 2
  • National Institute of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT05660083

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

A’ fastadhÌre 2
  • Georgetown University Medical Center, Washington D.C.
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT01042379

CtDNA Based MRD Testing for NAC Monitoring in TNBC

A’ fastadhSgrùdadh amharc
  • George Washington University, Washington D.C.
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 7 Faoi 2025 · NCT06230185

Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile

Sgrùdaidhean eile ann an Washington

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.